Click on headlines below to download research

Nearing prime time validation
e-Therapeutics | 05/01/2018

e-Therapeutics’ (ETX) Network-Driven Drug Discovery (NDD) platform has begun to deliver encouraging data that should support out-licensing of its…

Sailing a steady course
e-Therapeutics | 04/10/2017

e-Therapeutics’ (ETX) interim numbers demonstrate tight cost control and focus on the rationalised pipeline, with continued investment into the Network-Driven…

Executive interview - e-Therapeutics
Executive interview - e-Therapeutics | 09/08/2017

e-Therapeutics (ETX) is a UK-based drug discovery company that has developed a proprietary, computer-based discovery platform based on network biology.…